Global Antigen Rapid Test Market Growth 2025-2031

The global Antigen Rapid Test market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

United States market for Antigen Rapid Test is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Antigen Rapid Test is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Antigen Rapid Test is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Antigen Rapid Test players cover Abbott, Roche, BioMedomics, BD, Henry Schein, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Antigen Rapid Test Industry Forecast” looks at past sales and reviews total world Antigen Rapid Test sales in 2024, providing a comprehensive analysis by region and market sector of projected Antigen Rapid Test sales for 2025 through 2031. With Antigen Rapid Test sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antigen Rapid Test industry.

This Insight Report provides a comprehensive analysis of the global Antigen Rapid Test landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antigen Rapid Test portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antigen Rapid Test market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antigen Rapid Test and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antigen Rapid Test.

This report presents a comprehensive overview, market shares, and growth opportunities of Antigen Rapid Test market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

Covid-19-testing-related Rapid Tests

Rapid Strep Tests

Rapid Influenza Diagnostic Tests (RIDT)

Malaria Antigen Detection Tests

Segmentation by Application:

Hospitals

Scientific Research

Others

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

Abbott

Roche

BioMedomics

BD

Henry Schein

Safecare Bio-Tech

Mayo Clinic Laboratories

Chembio Diagnostics

Andon Health Co.,Ltd.

Ortho Clinical Diagnostics

Zhejiang Orient Gene Biotech

Oxford BioMedica

Affinity Biologicals

Epitope Diagnostics

Key Questions Addressed in this Report

What is the 10-year outlook for the global Antigen Rapid Test market?

What factors are driving Antigen Rapid Test market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Antigen Rapid Test market opportunities vary by end market size?

How does Antigen Rapid Test break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.